Ceredex Value Advisors’s Phibro Animal Health PAHC Stock Holding History

Ceredex Value Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-135,858	Closed	-$3.37M	–	163
2019 Q4	$3.37M	Sell	135,858 -64,685	-32%	-$1.5M	0.04%	134
2019 Q3	$4.28M	Sell	200,543 -637,200	-76%	-$17.5M	0.05%	140
2019 Q2	$26.6M	Sell	837,743 -48,903	-6%	-$1.53M	0.32%	100
2019 Q1	$29.3M	Buy	886,646 +48,694	+6%	+$1.52M	0.36%	91
2018 Q4	$26.9M	Sell	837,952 -11,472	-1%	-$433K	0.36%	94
2018 Q3	$36.4M	Sell	849,424 -227,049	-21%	-$10.7M	0.41%	92
2018 Q2	$49.6M	Sell	1,076,473 -60,881	-5%	-$2.7M	0.57%	82
2018 Q1	$45.2M	Buy	+1,137,354	New	+$42.1M	0.54%	88

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ceredex Value Advisors's PAHC Position: Q1 2020 in Review

Ceredex Value Advisors sold out of Phibro Animal Health (PAHC) in Q1 2020, closing a stake of 135,858 shares — an estimated $3.37M sold.

Ceredex Value Advisors first reported a position in PAHC in Q1 2018 and held it in 8 quarters. The position peaked at $49.6M in Q2 2018. 155 funds tracked by Wall St. Rank hold PAHC as of Q1 2020.

Ceredex Value Advisors reported no remaining Phibro Animal Health position as of Q1 2020 after selling out during the quarter.
Ceredex Value Advisors sold 135,858 Phibro Animal Health shares in Q1 2020, an estimated $3.37M.
Ceredex Value Advisors first reported a position in Phibro Animal Health in Q1 2018 and held it in 8 quarters.
Ceredex Value Advisors's Phibro Animal Health position peaked at $49.6M in Q2 2018.
155 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2020.

Based on Ceredex Value Advisors's 13F filing for Q1 2020, filed 12 May 2020.